num Vapocoolant for Breast Cancer

Phase-Based Progress Estimates
MD Anderson Cancer Center, Houston, TXBreast Cancernum Vapocoolant - Other
All Sexes
What conditions do you have?

Study Summary

This trial will study if a topical anesthetic spray reduces the pain of breast injections.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: through study completion; an average of 1 year.

Year 1
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

num Vapocoolant
1 of 1

Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: num Vapocoolant · No Placebo Group · N/A

num Vapocoolant
Experimental Group · 1 Intervention: num Vapocoolant · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion; an average of 1 year.

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,828 Previous Clinical Trials
1,792,738 Total Patients Enrolled
145 Trials studying Breast Cancer
31,706 Patients Enrolled for Breast Cancer
Sanjit Tewari, MDPrincipal InvestigatorM.D. Anderson Cancer Center

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Women with the ability to conceive, lactate or who are pregnant will be included.
You are at least 18 years of age.
Any adult patient who receives a subareolar breast lymphoscintigraphy injection is qualified.
You possess the capacity to comprehend and sign a written declaration of consent.

Frequently Asked Questions

What is the capacity of this medical trial in terms of recruitment?

"Correct. Data hosted on confirms that this medical experiment, which was initially posted on March 1st 2023, is actively recruiting participants. Approximately 30 individuals must be enrolled from a single site." - Anonymous Online Contributor

Unverified Answer

Are enrollees still being recruited for this experiment?

"Affirmative. The portal denotes that this trial, which was initially posted on March 1st 2023, is actively accepting participants. Approximately 30 patients need to be recruited from one of the given medical sites." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.